Misplaced Pages

Gidazepam

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Benzodiazepine medication Pharmaceutical compound
Gidazepam
Clinical data
Trade namesGidazepam IC
Routes of
administration
Oral
Legal status
Legal status
Pharmacokinetic data
MetabolismHepatic
Elimination half-life~87 hours
ExcretionRenal
Identifiers
IUPAC name
  • 2-(9-Bromo-3-oxo-6-phenyl-2,5-diazabicycloundeca-5,8,10,12-tetraen-2-yl)acetohydrazide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H15BrN4O2
Molar mass387.237 g·mol
3D model (JSmol)
SMILES
  • BrC1=CC2=C(C=C1)N(CC(NN)=O)C(CN=C2C3=CC=CC=C3)=O
InChI
  • InChI=1S/C17H15BrN4O2/c18-12-6-7-14-13(8-12)17(11-4-2-1-3-5-11)20-9-16(24)22(14)10-15(23)21-19/h1-8H,9-10,19H2,(H,21,23)
  • Key:XLGCMZLSEXRBSG-UHFFFAOYSA-N
  (what is this?)  (verify)

Gidazepam, also known as hydazepam or hidazepam, is a drug which is an atypical benzodiazepine derivative, developed in the Soviet Union. It is a selectively anxiolytic benzodiazepine. It also has therapeutic value in the management of certain cardiovascular disorders.

Pharmacology

Gidazepam and several of its analogs, in contrast to other benzodiazepines, are comparatively more selective agonists of TSPO (formerly the peripheral benzodiazepine receptor) than the benzodiazepine receptor.

Gidazepam acts as a prodrug to its active metabolite 7-bromo-2,3-dihydro-5-phenyl-1H-1,4-benzodiazepin-2-one (desalkylgidazepam or bromo-nordazepam). Its anxiolytic effects can take several hours to manifest presumably due to its slow metabolism (half-life 87 hours). The onset and intensity of anxiolytic effects correlate with blood levels of desalkylgidazepam.

Gidazepam active metabolite (desalkylgidazepam), responsible for its therapeutic effects

See also

References

  1. https://mozdocs.kiev.ua/likiview.php?id=33305 "Категорія відпуску. За рецептом."/"Leave Status: By Prescription"
  2. Library of Congress (2006). Library of Congress Subject Headings. Library of Congress. pp. 3300–.
  3. Spasennikov BA, Spasennikova MG (September 1991). "". Fel'dsher I Akusherka. 56 (9): 35–7. PMID 1684941.
  4. Neznamov GG, Koshelev VV, Voronina TA, Trofimov SS (Mar 2002). "". Eksperimental'naia i Klinicheskaia Farmakologiia. 65 (2): 12–6. PMID 12109283.
  5. ^ Korkhov VM, Tkachuk NA, Makan SY, Pavlovsky VI, Andronati SA (Feb 2002). "Affinities of gidazepam and its analogs for mitochondrial benzodiazepine receptors". Journal of Receptor and Signal Transduction Research. 22 (1–4): 411–20. doi:10.1081/RRS-120014610. PMID 12503630. S2CID 25403613.
  6. Morozov IS, Barchukov VG, Neznamov GG (Jan 1998). "". Eksperimental'naia i Klinicheskaia Farmakologiia. 61 (1): 30–2. PMID 9575408.
  7. Petrova TR, Tatarkin AN (1994). "". Terapevticheskii Arkhiv. 66 (9): 65–8. PMID 7992218.
  8. Skibitskiĭ VV, Kanorskiĭ SG (Sep 1993). "". Eksperimental'naia i Klinicheskaia Farmakologiia. 56 (5): 23–7. PMID 7906171.
  9. Skibitskiĭ VV, Petrova TR, Kanorskiĭ SG (June 1992). "". Kardiologiia. 32 (6): 35–7. PMID 1405290.
  10. Meerson FZ, Skibitskiĭ VV (April 1992). "". Kardiologiia. 32 (4): 25–30. PMID 1328745.
  11. Andronati SA, Zin'kovskiĭ VG, Totrova MI, Golovenko NI, Stankevich EA, Zhuk OV (January 1992). "". Biulleten' Eksperimental'noi Biologii I Meditsiny. 113 (1): 45–7. PMID 1356504.
  12. Kolyvanov GB, Zherdev VP, Chirkov AM, Otabekova SG, Litvin AA (May 1993). "". Eksperimental'naia i Klinicheskaia Farmakologiia. 56 (3): 48–50. PMID 8106054.
  13. Zherdev VP, Neznamov GG, Kolyvanov GB, Litvin AA, Otabekova SG (May 1993). "". Eksperimental'naia i Klinicheskaia Farmakologiia. 56 (3): 50–2. PMID 8106055.
Anxiolytics (N05B)
5-HT1ARTooltip 5-HT1A receptor agonists
GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators
Hypnotics
Gabapentinoids
(α2δ VDCC blockers)
Antidepressants
Antipsychotics
Sympatholytics
(Antiadrenergics)
Others
Benzodiazepines
1,4-Benzodiazepines
1,5-Benzodiazepines
2,3-Benzodiazepines*
Triazolobenzodiazepines
Imidazobenzodiazepines
Oxazolobenzodiazepines
Thienodiazepines
Thienotriazolodiazepines
Thienobenzodiazepines*
Pyridodiazepines
Pyridotriazolodiazepines
Pyrazolodiazepines
Pyrrolodiazepines
Tetrahydroisoquinobenzodiazepines
Pyrrolobenzodiazepines*
Benzodiazepine prodrugs
* atypical activity profile (not GABAA receptor ligands)
GABAA receptor positive modulators
Alcohols
Barbiturates
Benzodiazepines
Carbamates
Flavonoids
Imidazoles
Kava constituents
Monoureides
Neuroactive steroids
Nonbenzodiazepines
Phenols
Piperidinediones
Pyrazolopyridines
Quinazolinones
Volatiles/gases
Others/unsorted
See also: Receptor/signaling modulatorsGABA receptor modulatorsGABA metabolism/transport modulators
Stub icon

This sedative-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: